Yuping Li

Wenzhou Medical University - Department of Pulmonary and Critical Care Medicine

Wenzhou

China

  • Wenzhou Medical University - Department of Pulmonary and Critical Care Medicine

SCHOLARLY PAPERS

2

DOWNLOADS

251

TOTAL CITATIONS

0

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

Furmonertinib (AST2818) Versus Gefitinib as First-Line Therapy for Locally Advanced or Metastatic EGFR Mutation-Positive Non-Small Cell Lung Cancer: A Multi-Center, Double-Blind, Randomized Phase 3 Study (FURLONG)

Number of pages: 53 Posted: 10 Jan 2022
Yuankai Shi, Gongyan Chen, Xiang Wang, Yunpeng Liu, Lin Wu, Yanrong Hao, Chunling Liu, Shuyang Zhu, Xiaodong Zhang, Yuping Li, Jiwei Liu, Lejie Cao, Ying Cheng, Hui Zhao, Shucai Zhang, Aimin Zang, Jiuwei Cui, Jian Feng, Fei Liu, Yong Jiang and Chuan Gu
Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs, Harbin Medical University - Department of Medical Oncology, Xuzhou Central Hospital - Department of Medical Oncology, China Medical University - Department of Medical Oncology, Zhengzhou University - Henan Provincial People's Hospital, The People's Hospital of Guangxi Zhuang Autonomous Region - Department of Medical Oncology, Xinjiang Medical University - Department of Pulmonary Medicine, Xuzhou Medical College - Department of Respiratory Medicine, Nantong Tumor Hospital - Department of Medical Oncology, Wenzhou Medical University - Department of Pulmonary and Critical Care Medicine, Dalian University - Department of Oncology, University of Science and Technology of China (USTC) - Department of Respiratory Medicine, Jilin Cancer Hospital - Department of Oncology, Anhui Medical University - Department of Respiratory and Critical Care Medicine, Capital Medical University - Department of Oncology, Hebei University - Department of Medical Oncology, Jilin University (JLU) - Cancer Center, Nantong University - Department of Respiratory Medicine, Shanghai Allist Pharmaceutical Technology, Shanghai Allist Pharmaceutical Technology and Shanghai Allist Pharmaceutical Technology
Downloads 222 (297,117)

Abstract:

Loading...

Furmonertinib, AST2818, NSCLC, EGFR, TKI

2.

Myristoyl Lysophosphatidylcholine is a Biomarker and Potential Therapeutic Target for Community-Acquired Pneumonia

Number of pages: 40 Posted: 28 Nov 2022
Wengang Nan, Fen Xiong, Hong Zheng, Chen Li, Cong Lou, Xiong Lei, Huizhen Wu, Hongchang Gao and Yuping Li
Wenzhou Medical University - Department of Pulmonary and Critical Care Medicine, Wenzhou Medical University - (Zhejiang Lab for Regenerative Medicine, Vision and Brain Health, Wenzhou Medical University - (Zhejiang Lab for Regenerative Medicine, Vision and Brain Health, Wenzhou Medical University - (Zhejiang Lab for Regenerative Medicine, Vision and Brain Health, Wenzhou Medical University - (Zhejiang Lab for Regenerative Medicine, Vision and Brain Health, Wenzhou Medical University - Department of Pulmonary and Critical Care Medicine, Wenzhou Medical University - Department of Pulmonary and Critical Care Medicine, Wenzhou Medical University - (Zhejiang Lab for Regenerative Medicine, Vision and Brain Health and Wenzhou Medical University - Department of Pulmonary and Critical Care Medicine
Downloads 29 (1,050,689)

Abstract:

Loading...

Community-acquired pneumonia, Acute lung injury, Biomarker, Metabolomics, NLRP3 inflammasome.